Orca Pharmaceuticals, LLC — Form D/A
Orca Pharmaceuticals, LLC of CLEVELAND, OH, a company, filed a Form D amendment with the SEC on 2014-03-17. The offering totals $5.0M, of which $1.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-03-17
- Form: D/A
- Accession: 0001575447-14-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.2M
- Remaining: $3.8M
- Investors: 8
- Date of first sale: 2013-08-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-202057
Issuer
- Name: Orca Pharmaceuticals, LLC
- CIK: 0001575447
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 20600 CHAGRIN BLVD., CLEVELAND, OH, 44122
- Phone: 216-455-3216
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Thomas Facklam | Director | Cleveland, OH |
| Michael Hunter | Director | New York, NY |
| Baiju Shah | Director | Cleveland, OH |
| Baiju Shah | Promoter | Cleveland, OH |
| Theodore Torphy | Director | Cleveland, OH |
| DAVID U'PRICHARD | Director | LONDON, X0 |
| Al Hawkins | Promoter | Cleveland, OH |
| Roy Pettipher | Director | Cleveland, OH |
Other filings by this issuer (2)
More